KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Total Current Liabilities (2018 - 2024)

BioNTech SE's Total Current Liabilities history spans 7 years, with the latest figure at $2.7 billion for Q4 2024.

  • For Q4 2024, Total Current Liabilities rose 21.03% year-over-year to $2.7 billion; the TTM value through Dec 2024 reached $2.7 billion, up 21.03%, while the annual FY2024 figure was $2.7 billion, 21.93% up from the prior year.
  • Total Current Liabilities for Q4 2024 was $2.7 billion at BioNTech SE, up from $2.2 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $4.0 billion in Q4 2021 and bottomed at $722.5 million in Q4 2020.
  • The 5-year median for Total Current Liabilities is $2.7 billion (2024), against an average of $2.5 billion.
  • The largest annual shift saw Total Current Liabilities soared 451.24% in 2021 before it dropped 26.0% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $722.5 million in 2020, then skyrocketed by 451.24% to $4.0 billion in 2021, then fell by 24.42% to $3.0 billion in 2022, then decreased by 26.0% to $2.2 billion in 2023, then grew by 21.03% to $2.7 billion in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Total Current Liabilities are $2.7 billion (Q4 2024), $2.2 billion (Q4 2023), and $3.0 billion (Q4 2022).